Vertex Pharma’s three-drug combinations improve breathing in some cystic fibrosis patients
July 18, 2017 at 16:01 PM EDT
Vertex is attempting to expand treatment options to about 40 percent of cystic fibrosis patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.